Skip to Main Content

WASHINGTON — The federal government is spending more money on brand-name drugs for seniors in the Medicare Part D program, even as the number of prescriptions falls, a government watchdog report released Monday concluded.

The analysis, conducted by the Department of Health and Human Services Office of Inspector General, landed in Washington amid talks of radical changes to the Part D program, which typically covers drugs dispensed at a pharmacy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.